S-1 has also been shown to be a potent radiosensitizer in human solid tumour xenograft (Fukushima et al, 1998; Harada et al, 2004), which suggests that the combination of radiotherapy and S-1 may improve survival in patients with locally advanced pancreatic cancer. Here, PSMD1 is linked to pancreatic neoplasm.